Destiny Pharma.
36 announcements.
36 announcements.
Time | Date | Ticker | Company | Announcement |
---|---|---|---|---|
07:00 | 13-08-2024 | DEST | Destiny Pharma | Cancellation - Destiny Pharma plc |
07:00 | 12-08-2024 | DEST | Destiny Pharma | Last Day of Dealings on AIM |
11:58 | 05-08-2024 | DEST | Destiny Pharma | Director/PDMR Shareholding |
11:00 | 31-07-2024 | DEST | Destiny Pharma | Result of GM and Cancellation of Trading on AIM |
07:00 | 15-07-2024 | DEST | Destiny Pharma | Proposed Cancellation of Admission to Trading |
07:00 | 20-06-2024 | DEST | Destiny Pharma | Exercise of Options and Total Voting Rights |
07:00 | 18-06-2024 | DEST | Destiny Pharma | Efficacy of XF-70 in Fungal Skin Infections |
12:16 | 12-06-2024 | DEST | Destiny Pharma | Result of Annual General Meeting |
11:00 | 12-06-2024 | DEST | Destiny Pharma | 2024 Annual General Meeting and Statement |
07:00 | 11-06-2024 | DEST | Destiny Pharma | Destiny Pharma's XF-73 Nasal Awarded MHRA ILAP |
07:00 | 24-05-2024 | DEST | Destiny Pharma | Exercise of Options and Total Voting Rights |
14:35 | 09-05-2024 | DEST | Destiny Pharma | Posting of Annual Report and Notice of AGM |
07:00 | 25-04-2024 | DEST | Destiny Pharma | Full year results and review of strategic options |
07:00 | 08-04-2024 | DEST | Destiny Pharma | Notice of Full Year Results |
14:47 | 19-03-2024 | DEST | Destiny Pharma | Exercise of Options and Total Voting Rights |
07:00 | 31-01-2024 | DEST | Destiny Pharma | Clinical development update |
07:00 | 22-01-2024 | DEST | Destiny Pharma | Appointment of Nominated Adviser and Sole Broker |
07:00 | 04-01-2024 | DEST | Destiny Pharma | Year End Business Update |
07:00 | 20-10-2023 | DEST | Destiny Pharma | Grant of Share Options |
07:00 | 19-10-2023 | DEST | Destiny Pharma | Director/PDMR Shareholding |
07:01 | 17-10-2023 | DEST | Destiny Pharma | XF Pipeline Update Meeting |
07:00 | 17-10-2023 | DEST | Destiny Pharma | Publication of new microbiological data for XF-73 |
07:00 | 10-10-2023 | DEST | Destiny Pharma | Director/PDMR Shareholding |
12:34 | 04-10-2023 | DEST | Destiny Pharma | Director/PDMR Shareholding |
07:00 | 27-09-2023 | DEST | Destiny Pharma | Notice of XF Pipeline Update Meeting |
07:00 | 20-09-2023 | DEST | Destiny Pharma | Interim Results |
12:01 | 31-07-2023 | DEST | Destiny Pharma | Publication of new data for XF-73 |
07:00 | 25-07-2023 | DEST | Destiny Pharma | Appointment of new Chairman |
12:55 | 19-07-2023 | DEST | Destiny Pharma | Board changes including appointment of new CEO |
07:00 | 07-07-2023 | DEST | Destiny Pharma | Exercise of Options and Total Voting Rights |
07:00 | 29-06-2023 | DEST | Destiny Pharma | Business Update |
15:27 | 26-05-2023 | DEST | Destiny Pharma | Director/PDMR Shareholding |
07:00 | 26-05-2023 | DEST | Destiny Pharma | Director Dealing |
12:23 | 25-05-2023 | DEST | Destiny Pharma | Result of Annual General Meeting |
07:00 | 25-05-2023 | DEST | Destiny Pharma | Dr Debra Barker Appointed Interim CEO |
12:24 | 12-05-2023 | DEST | Destiny Pharma | Grant of Share Options |